Breast cancer patients with obesity who were assigned to adjuvant chemotherapy had a higher risk of BCR compared with breast cancer patients with a healthy weight (HRadj = 2.06 [95%CI 1.08–4.31]). This evidence concerns the gene BCR and obesity disorder.